SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (1611)10/26/2005 4:16:48 PM
From: Icebrg  Read Replies (1) of 1826
 
Tuck,

Sorry, I have no idea whatsoever. Generally speaking Europe should be a very difficult "market" to penetrate. Even if there is one central authority for approval a successful company must set up separate salesforces, if not two, in each individual country (due to different languages, cultures, customs, treatment preferences, regulators etc. etc.). This is clearly something neither MGI or Supergen will be able to do on their own. The eventual success of Dacogen will depend more on with whom they partner than on the timeline for approval. I generally tend to disregard European sales possibilities for companies, who don't have the sales force to match the requirements here. And those who have are to large to be of interest to me.

Integrilin is a good example of a superior drug with very limited sales in Europe.

I too believe this is an overreaction. Maybe someone looked for a reason to sell and now they got one. With or without merit. I believe the main questionmark overhanging MGI is that they are now spending the money they are making on Aloxi on further drug development. No harvest times yet, with other words. This may have been a disappointment for investors, who thought they would see a profitable company emerging out of the ashes of Irofulven.

One the other hand, the sky or a place relatively close to it will be the limit, if they manage to get a couple of drugs through, all the way to approval.

Erik
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News